ADDvise Group AB (publ) (ADDV-A.ST)
SEK 11.2
(1.36%)
SEK 11.2
(1.36%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.22 Billion SEK | 84.01% |
| 2022 | 666.76 Million SEK | 191.86% |
| 2021 | 228.45 Million SEK | 48.57% |
| 2020 | 153.76 Million SEK | -15.88% |
| 2019 | 182.79 Million SEK | 4.75% |
| 2018 | 174.5 Million SEK | 11.24% |
| 2017 | 156.87 Million SEK | 48.73% |
| 2016 | 105.47 Million SEK | 22.93% |
| 2015 | 85.8 Million SEK | -14.45% |
| 2014 | 100.29 Million SEK | 152.83% |
| 2013 | 39.67 Million SEK | 87.24% |
| 2012 | 21.18 Million SEK | 2118800.0% |
| 2011 | -1000.00 SEK | -100.04% |
| 2010 | 2.81 Million SEK | 0.0% |
| 2008 | 415 Thousand SEK | 141.28% |
| 2007 | 172 Thousand SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.29 Billion SEK | 5.67% |
| 2024 Q3 | 1.45 Billion SEK | -3.78% |
| 2024 Q2 | 1.51 Billion SEK | 16.59% |
| 2023 Q2 | 534.5 Million SEK | -10.33% |
| 2023 Q1 | 596.1 Million SEK | -10.6% |
| 2023 Q3 | 550.8 Million SEK | 3.05% |
| 2023 FY | 1.22 Billion SEK | 84.01% |
| 2023 Q4 | 1.22 Billion SEK | 122.75% |
| 2022 Q4 | 666.76 Million SEK | 53.04% |
| 2022 FY | 666.76 Million SEK | 191.86% |
| 2022 Q1 | 276.49 Million SEK | 21.03% |
| 2022 Q2 | 450.73 Million SEK | 63.02% |
| 2022 Q3 | 435.68 Million SEK | -3.34% |
| 2021 Q3 | 182.73 Million SEK | -8.89% |
| 2021 Q4 | 228.45 Million SEK | 25.02% |
| 2021 Q1 | 119.47 Million SEK | -22.3% |
| 2021 Q2 | 200.55 Million SEK | 67.86% |
| 2021 FY | 228.45 Million SEK | 48.57% |
| 2020 Q2 | 170.71 Million SEK | -2.79% |
| 2020 Q4 | 153.76 Million SEK | -12.6% |
| 2020 Q3 | 175.92 Million SEK | 3.05% |
| 2020 Q1 | 175.61 Million SEK | -3.93% |
| 2020 FY | 153.76 Million SEK | -15.88% |
| 2019 FY | 182.79 Million SEK | 4.75% |
| 2019 Q4 | 182.79 Million SEK | -5.18% |
| 2019 Q2 | 186.73 Million SEK | 16.49% |
| 2019 Q1 | 160.3 Million SEK | -8.14% |
| 2019 Q3 | 192.77 Million SEK | 3.23% |
| 2018 FY | 174.5 Million SEK | 11.24% |
| 2018 Q4 | 174.5 Million SEK | -2.08% |
| 2018 Q3 | 178.22 Million SEK | 10.1% |
| 2018 Q2 | 161.87 Million SEK | 3.39% |
| 2018 Q1 | 156.57 Million SEK | -0.19% |
| 2017 Q4 | 156.87 Million SEK | 24.44% |
| 2017 Q3 | 126.06 Million SEK | 1.96% |
| 2017 Q2 | 123.64 Million SEK | 2.65% |
| 2017 Q1 | 120.44 Million SEK | 14.2% |
| 2017 FY | 156.87 Million SEK | 48.73% |
| 2016 Q4 | 105.47 Million SEK | -5.43% |
| 2016 Q3 | 111.52 Million SEK | 13.91% |
| 2016 Q2 | 97.9 Million SEK | 1.83% |
| 2016 Q1 | 96.14 Million SEK | 12.05% |
| 2016 FY | 105.47 Million SEK | 22.93% |
| 2015 Q1 | 94.42 Million SEK | -5.85% |
| 2015 Q2 | 82.82 Million SEK | -12.29% |
| 2015 Q4 | 85.8 Million SEK | -3.65% |
| 2015 Q3 | 89.05 Million SEK | 7.52% |
| 2015 FY | 85.8 Million SEK | -14.45% |
| 2014 FY | 100.29 Million SEK | 152.83% |
| 2014 Q4 | 100.29 Million SEK | 121.01% |
| 2014 Q3 | 45.38 Million SEK | 8.31% |
| 2014 Q2 | 41.9 Million SEK | -0.09% |
| 2014 Q1 | 41.93 Million SEK | 5.72% |
| 2013 Q3 | 40.7 Million SEK | 818.62% |
| 2013 Q4 | 39.67 Million SEK | -2.54% |
| 2013 FY | 39.67 Million SEK | 87.24% |
| 2013 Q1 | 17.26 Million SEK | -18.5% |
| 2013 Q2 | 4.43 Million SEK | -74.34% |
| 2012 Q3 | 21.88 Million SEK | 11.17% |
| 2012 FY | 21.18 Million SEK | 2118800.0% |
| 2012 Q1 | 9.72 Million SEK | 972500.0% |
| 2012 Q4 | 21.18 Million SEK | -3.2% |
| 2012 Q2 | 19.68 Million SEK | 102.47% |
| 2011 Q4 | -1000.00 SEK | -100.03% |
| 2011 FY | -1000.00 SEK | -100.04% |
| 2011 Q2 | 3.56 Million SEK | 48.46% |
| 2011 Q1 | 2.4 Million SEK | -14.8% |
| 2011 Q3 | 3.08 Million SEK | -13.56% |
| 2010 Q2 | -4.12 Million SEK | -426.85% |
| 2010 FY | 2.81 Million SEK | 0.0% |
| 2010 Q1 | -782 Thousand SEK | 0.0% |
| 2010 Q4 | 2.81 Million SEK | 139.9% |
| 2010 Q3 | -7.06 Million SEK | -71.36% |
| 2009 Q1 | 415 Thousand SEK | 151.43% |
| 2009 Q2 | -581 Thousand SEK | -240.0% |
| 2008 FY | 415 Thousand SEK | 141.28% |
| 2008 Q4 | -807 Thousand SEK | 0.0% |
| 2008 Q1 | 172 Thousand SEK | 0.0% |
| 2007 FY | 172 Thousand SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acarix AB (publ) | -35.14 Million SEK | 3590.569% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 0.0% |
| Arcoma AB | -1.12 Million SEK | 108867.73% |
| Bactiguard Holding AB (publ) | 109.88 Million SEK | -1016.561% |
| BICO Group AB (publ) | 927.9 Million SEK | -32.223% |
| Boule Diagnostics AB (publ) | 128.8 Million SEK | -852.562% |
| CellaVision AB (publ) | -56.94 Million SEK | 2254.649% |
| Clinical Laserthermia Systems AB (publ) | -14.87 Million SEK | 8346.958% |
| Chordate Medical Holding AB (publ) | -8.45 Million SEK | 14610.58% |
| C-Rad AB (publ) | -127.6 Million SEK | 1061.52% |
| Duearity AB (publ) | 10.23 Million SEK | -11891.985% |
| Dignitana AB (publ) | 13.07 Million SEK | -9282.121% |
| Episurf Medical AB (publ) | -52.7 Million SEK | 2428.083% |
| Getinge AB (publ) | 5.4 Billion SEK | 77.313% |
| Scandinavian Real Heart AB (Publ) | -35.05 Million SEK | 3600.12% |
| Iconovo AB (publ) | -10.75 Million SEK | 11507.362% |
| Integrum AB (publ) | -10.47 Million SEK | 11810.932% |
| Luxbright AB (publ) | -13.83 Million SEK | 8969.072% |
| Mentice AB (publ) | -49.56 Million SEK | 2575.385% |
| OssDsign AB (publ) | -162.78 Million SEK | 853.68% |
| Paxman AB (publ) | -11.41 Million SEK | 10851.906% |
| Promimic AB (publ) | -50.32 Million SEK | 2538.05% |
| Qlife Holding AB (publ) | 19.07 Million SEK | -6333.665% |
| SciBase Holding AB (publ) | -27.32 Million SEK | 4590.192% |
| ScandiDos AB (publ) | -1.53 Million SEK | 80237.165% |
| Sectra AB (publ) | -772.85 Million SEK | 258.75% |
| Sedana Medical AB (publ) | -226.87 Million SEK | 640.785% |
| Senzime AB (publ) | -139.54 Million SEK | 979.24% |
| SpectraCure AB (publ) | -50.23 Million SEK | 2542.37% |
| Stille AB | -178.5 Million SEK | 787.324% |
| Vitrolife AB (publ) | 1.22 Billion SEK | 0.09% |
| Xvivo Perfusion AB (publ) | -214.65 Million SEK | 671.579% |